Methods of promoting wound healing using CRM1 inhibitors
Abstract:
The invention generally relates to the use of nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula I: or a pharmaceutically acceptable salt thereof, wherein Ring A, X, R1, R2 and n are as defined and described herein, in a method for promoting wound healing in a subject.
Public/Granted literature
Information query
Patent Agency Ranking
0/0